Increased Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 gag Gene

A major challenge for the next generation of human immunodeficiency virus (HIV) vaccines is the induction of potent, broad, and durable cellular immune responses. The structural protein Gag is highly conserved among the HIV type 1 (HIV-1) gene products and is believed to be an important target for t...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	J Virol
Päätekijät:	zur Megede, Jan, Chen, Min-Chao, Doe, Barbara, Schaefer, Mary, Greer, Catherine E., Selby, Mark, Otten, Gillis R., Barnett, Susan W.
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 2000
Aiheet:	Vaccines and Antiviral Agents
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC111751/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10684277/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.74.6.2628-2635.2000
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!